Skip to Content

Orthofix Medical Inc.

Corporate Governance / Derivative

  • Date:
  • 10/29/2024
  • Company Name:
  • Orthofix Medical Inc.
  • Stock Symbol:
  • OFIX
  • Class Period:
  • FROM 10/11/2022 TO 9/12/2023
  • Status:
  • Filed
  • Filing Date:
  • 8/21/2024
  • Court:
  • U.S. District Court: Eastern Texas

Case Finder

Locate any case using the tools below.

Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Orthofix Medical Inc. (NASDAQ: OFIX) on behalf of long-term stockholders following a class action complaint that was filed against Orthofix on August 21, 2024 with a Class Period from October 11, 2022 to September 12, 2023. Our investigation concerns whether the board of directors of Orthofix have breached their fiduciary duties to the company.

According to the Complaint, the Company made false and misleading statements to the market. Orthofix failed to disclose that certain members of its membership team engaged in repeated instances of offensive and inappropriate conduct. The Company’s failure to inform investors of the truth became apparent on September 12, 2023, when its Board of Directors decided to terminate the offending members of the management team. Based on these facts, the Company’s public statements were false and materially misleading throughout the class period. When the market learned the truth about Orthofix, investors suffered damages.
 
If you are a long-term stockholder of Orthofix, have information, would like to learn more about these claims, or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Brandon Walker or Marion Passmore by email at investigations@bespc.com, by telephone at (212) 355-4648, or by filling out the form below. There is no cost or obligation to you.
The individual or institution below (“Plaintiff”) has reviewed and agrees to the Bragar Eagel & Squire, P.C. (“BESPC”) retainer agreement and authorizes BESPC to prosecute an action on Plaintiff’s behalf under the federal securities laws or applicable state laws to recover damages on behalf of investors in Orthofix Medical Inc.. BESPC will prosecute the action on a full contingency basis and will forward all costs and expenses.
 

Case Finder

Locate any case using the tools below.

You may share a link to this page on any of the sites listed below or send link via email: